(One typical response: Drowning in cologne over here if you want to chat with Leo
Baseline levels of GHK-Cu in the human body peak at roughly 200 ng/mL during late adolescence (around age 20), but suffer a precipitous and permanent decline as an individual ages, dropping to approximately 80 ng/mL by age 60
Patients with certain genetic profiles may experience more pronounced nausea, faster weight loss, or different hunger patterns
Some men report increased energy, sharper focus, and better sleep within 2472 hours of their first injection
[5] BPC-157 Dosage: Translating Animal Data to Human Protocols Translating rodent doses to human equivalents requires a conversion factor that accounts for differences in metabolic rate and body surface area
Concentration and Dosing Differences Each copper peptide type has different effective concentration ranges